As of 2025-07-16, the Intrinsic Value of Mehadrin Ltd (MEDN.TA) is 42,398.27 ILS. This MEDN.TA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 30,000.00 ILS, the upside of Mehadrin Ltd is 41.30%.
The range of the Intrinsic Value is 25,618.05 - 90,607.93 ILS
Based on its market price of 30,000.00 ILS and our intrinsic valuation, Mehadrin Ltd (MEDN.TA) is undervalued by 41.30%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 25,618.05 - 90,607.93 | 42,398.27 | 41.3% |
| DCF (Growth 10y) | 47,962.66 - 151,412.04 | 74,839.51 | 149.5% |
| DCF (EBITDA 5y) | 11,607.21 - 19,561.54 | 14,540.32 | -51.5% |
| DCF (EBITDA 10y) | 29,813.91 - 46,894.95 | 36,456.67 | 21.5% |
| Fair Value | -33,903.75 - -33,903.75 | -33,903.75 | -213.01% |
| P/E | (10,903.47) - (13,859.88) | (11,968.05) | -139.9% |
| EV/EBITDA | (7,221.04) - (6,429.93) | (6,934.00) | -123.1% |
| EPV | (14,392.35) - (17,021.76) | (15,707.07) | -152.4% |
| DDM - Stable | (9,544.95) - (29,198.85) | (19,371.89) | -164.6% |
| DDM - Multi | 19,450.26 - 48,514.20 | 28,041.59 | -6.5% |
| Market Cap (mil) | 873.91 |
| Beta | 0.15 |
| Outstanding shares (mil) | 0.03 |
| Enterprise Value (mil) | 1,129.94 |
| Market risk premium | 6.13% |
| Cost of Equity | 10.06% |
| Cost of Debt | 5.71% |
| WACC | 8.34% |